Scott Asher, MD
Plastic Surgery Within the Head and Neck · Dothan, ALNPI 1316109978
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 40.0% of the total.
Across 87 payments — averaging $27.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$945
- Galderma Laboratories, L.p.$307
- Organogenesis Inc.$288
- Revance Therapeutics, Inc.$239
- Merz North America, Inc.$122
- Mentor Worldwide LLC$115
- plus $349 from 7 others
What the payments were for
- Food & beverage$2,365100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $945 |
| Galderma Laboratories, L.p. | 8 | $307 |
| Organogenesis Inc. | 19 | $288 |
| Revance Therapeutics, Inc. | 4 | $239 |
| Merz North America, Inc. | 2 | $122 |
| Mentor Worldwide LLC | 4 | $115 |
| Regeneron Healthcare Solutions, Inc. | 1 | $90 |
| Kerecis Limited | 1 | $68 |
| Pacira Pharmaceuticals Incorporated | 2 | $47 |
| Davol Inc. | 1 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $46 |
| Sanofi | 2 | $32 |
| LEO Pharma Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAXXIFY$113
How this compares
Too few plastic surgery within the head and neck providers in Alabamato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 33 | $290 |
| ErythromycinErythromycin Base | 14 | $181 |
| Ondansetron Hcl | 20 | $173 |
| ValacyclovirValacyclovir Hcl | 13 | $127 |
| Cephalexin | 16 | $108 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery within the head and neck in Dothan
- Harishanker JeyarajanBirmingham$150K
- Artemus CoxBirmingham$5K
- Beau VandiverMountain Brk$2K
- Blake RaggioMontgomery$980
- Susan McCammonBirmingham$482
- Ed McColloughGulf Shores$471
- Glenn PetersBirmingham$132
- Frederick SilverMobile$13
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.